Health Condition 1: G318- Other specified degenerative diseases of nervous system Health Condition 2: G968- Other specified disorders of central nervous system
Conditions
Interventions
Intervention1: control group: No block will be given. No intervention will be done
Intervention2: Test group: 20 ml of o.375% ropivacaine on each side with total of 40 ml on both sides
Sponsors
Nizams Institute of Medical sciences
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1-2 Elective surgery
Exclusion criteria
Exclusion criteria: History of bleeding diathesis, receiving anticoagulant treatment, known allergies to medications used in the study (local anaesthetics, non-steroidal anti-inflammatory drugs, and opioids), skin infections at the site of block area, pregnancy or lactation, and refusal to participate in the study. ) patients with severe visual and auditory disorders;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scaleTimepoint: 15 minutes, 30 minutes, 45 minutes, 1 hour, 4 hours, 8 hours, 12 hours, 16 hours and 24 hours postoperatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| intraop haemodynamics and fentayl , postop nausea, vomiting, patient satisfaction, post op fentanyl and paracetomolTimepoint: postop fentanyl requirement: postop first four hoursparaceomol: in first twenty four hours | — |
Countries
India
Contacts
Public ContactSingam Geetha
Nizams Institute of Medical Sciences
Outcome results
None listed